These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1159419)

  • 1. Sequential analysis: manganese, catecholamines and L-dopa induced dyskinesia.
    Papavasiliou PS; Miller ST; Cotzias GC; Kraner HW; Hsieh RS
    J Neurochem; 1975 Sep; 25(3):215-9. PubMed ID: 1159419
    [No Abstract]   [Full Text] [Related]  

  • 2. Some biochemical and behavioural correlates of a possible animal model of human hyperkinetic syndromes.
    McKenzie GM; Gordon RJ; Viik K
    Brain Res; 1972 Dec; 47(2):439-56. PubMed ID: 4404908
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral and biochemical effects of L-DOPA in cats.
    Kitsikis A; Roberge A
    Isr J Med Sci; 1973; 9 Suppl():17-23. PubMed ID: 10189868
    [No Abstract]   [Full Text] [Related]  

  • 4. The modification of L-dopa induced dyskinesias in the monkey by unilateral nigral lesions.
    Mones RJ; Pasik P; Pasik T; Wilk S
    Trans Am Neurol Assoc; 1973; 98():234-7. PubMed ID: 4206371
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology of drug-induced dyskinesias.
    Korczyn AD
    Neuropharmacology; 1972 Sep; 11(5):601-7. PubMed ID: 4275111
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of chronically administered L-dopa in normal and lesioned cats.
    Langelier P; Roberge AG; Boucher R; Poirier LJ
    J Pharmacol Exp Ther; 1973 Oct; 187(1):15-26. PubMed ID: 4746324
    [No Abstract]   [Full Text] [Related]  

  • 7. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
    Marsden CD
    Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
    [No Abstract]   [Full Text] [Related]  

  • 8. Atipamezole, an alpha2-adrenoceptor antagonist, augments the effects of L-DOPA on evoked dopamine release in rat striatum.
    Yavich L; Sirviö J; Haapalinna A; Ylinen A; Männistö PT
    Eur J Pharmacol; 2003 Feb; 462(1-3):83-9. PubMed ID: 12591099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fine structure of cerebellar lesions after L-dopa administration in the dog.
    Reger JF; Holbrook JR; Pozos RS
    Exp Neurol; 1972 Jun; 35(3):480-91. PubMed ID: 5035156
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of -methyl-meta-tyrosine on spontaneous and caudate-induced electroencephalogram activity and regional catecholamines in the cat brain.
    Shellenberger MK
    J Pharmacol Exp Ther; 1971 Jun; 177(3):481-90. PubMed ID: 5568803
    [No Abstract]   [Full Text] [Related]  

  • 11. Progesterone enhances L-dopa-stimulated dopamine release from the caudate nucleus of freely behaving ovariectomized-estrogen-primed rats.
    Dluzen DE; Ramirez VD
    Brain Res; 1989 Aug; 494(1):122-8. PubMed ID: 2765910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional studies of catecholamines in the rat brain. 3. Subcellullar distribution of endogenous and exogenous catecholamines in various brain regions.
    Glowinski J; Iversen L
    Biochem Pharmacol; 1966 Jul; 15(7):977-87. PubMed ID: 5967909
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of L-DOPA on the synthesis and excretion of tyramine.
    Boulton AA; Wu PH
    Adv Neurol; 1974; 5():119-25. PubMed ID: 4613157
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of dihydroxyphenylalanine, pheniprazine and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus.
    McKenzie GM; Szerb JC
    J Pharmacol Exp Ther; 1968 Aug; 162(2):302-8. PubMed ID: 4385909
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of dopa on the norepinephrine and dopamine contents and on the granulated vesicles of the hypothalamus of reserpinized rabbits.
    Hashimoto Y; Ishii S; Ohi Y; Shimizu N; Imaizumi R
    Jpn J Pharmacol; 1965 Dec; 15(4):395-400. PubMed ID: 5296051
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of L-dopa on the hypothalamic, pineal and striatal monoamines and on the sexual behaviour of the rat.
    Hyyppä M; Lehtinen P; Rinne UK
    Brain Res; 1971 Jul; 30(2):265-72. PubMed ID: 5315473
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys.
    Ouattara B; Gasparini F; Morissette M; Grégoire L; Samadi P; Gomez-Mancilla B; Di Paolo T
    J Neurochem; 2010 May; 113(3):715-24. PubMed ID: 20132464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain.
    Glowinski J; Iversen LL
    J Neurochem; 1966 Aug; 13(8):655-69. PubMed ID: 5950056
    [No Abstract]   [Full Text] [Related]  

  • 20. Alcohol effects on EEG and multiple-unit activity in various brain regions of rats.
    Klemm WR; Stevens RE
    Brain Res; 1974 Apr; 70(2):361-8. PubMed ID: 4825679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.